ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 61 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -66.7% | 300 | -76.9% | 0.00% | -100.0% |
| Q2 2017 | $3,000 | 0.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $3,000 | 0.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,000 | -40.0% | 1,300 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $5,000 | +66.7% | 1,300 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $3,000 | -25.0% | 1,300 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $4,000 | -20.0% | 1,300 | 0.0% | 0.00% | -60.0% |
| Q4 2015 | $5,000 | +25.0% | 1,300 | 0.0% | 0.01% | +150.0% |
| Q3 2015 | $4,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |